Literature DB >> 11383766

Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy.

H Xu1, S Liu, X Xia, P Huang, P Wang, X Wu.   

Abstract

PURPOSE: To investigate the effects of mitomycin C on haze after photorefractive keratectomy (PRK).
METHODS: Twenty of 24 rabbits underwent bilateral 193-nm excimer laser PRK to correct -10.00 D of myopia; the remaining four rabbits were not operated (no PRK group). The right eyes of the 20 rabbits were treated with 0.02% mitomycin C during surgery (PRK+MMC group) and the left eyes did not receive 0.02% mitomycin C (PRK alone group). Clinical and histopathologic examinations were performed.
RESULTS: The most severe haze in the PRK alone group after PRK reached grade 3; the PRK+MMC group did not exceed grade 1 haze. Statistically significant differences were found between the PRK+MMC and PRK alone groups from week 2 to week 26 after treatment (P<.01). Epithelial thickening appeared for 26 weeks in both PRK groups; no statistically significant differences were found between the two PRK groups (P>.05). A marked reduction of keratocytes in the anterior stroma of the PRK+MMC group was observed. At week 1, 2, and 4 after PRK, keratocytes of the PRK+MMC group were only 3.1+/-2.6, 6.8+/-4.7, and 12.4+/-5.7 keratocytes x 10(4)/microm2, respectively, while those of the PRK alone group were 41.2+/-80, 42.3+/-7.8, and 40.0+/-3.3 keratocytes x 10(4)/microm2, respectively. There were statistically significant differences between the two groups (P<.001).
CONCLUSION: A single intraoperative application of topical mitomycin C during PRK in rabbits reduced corneal haze by inhibiting the proliferation of keratocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383766     DOI: 10.3928/1081-597X-20010501-08

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  9 in total

Review 1.  Corneal Regeneration After Photorefractive Keratectomy: A Review.

Authors:  Javier Tomás-Juan; Ane Murueta-Goyena Larrañaga; Ludger Hanneken
Journal:  J Optom       Date:  2014-10-23

2.  Detection of corneal fibrosis by imaging second harmonic-generated signals in rabbit corneas treated with mitomycin C after excimer laser surface ablation.

Authors:  Marjan Farid; Naoyuki Morishige; Larry Lam; Andrew Wahlert; Roger F Steinert; James V Jester
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-23       Impact factor: 4.799

Review 3.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Two-step versus Single Application of Mitomycin-C in Photorefractive Keratectomy for High Myopia.

Authors:  Farhad Fazel; Leila Roshani; Leila Rezaei
Journal:  J Ophthalmic Vis Res       Date:  2012-01

5.  Comparison of standard and low dose intraoperative mitomycin C in prevention of corneal hazeafter photorefractive keratectomy.

Authors:  Hassan Razmjoo; Mohammad Reza Kooshanmehr; Alireza Peyman; Zahra Kor; Erfan Mohammadesmaeil
Journal:  Int J Prev Med       Date:  2013-02

6.  Quiescent keratocytes fail to repair MMC induced DNA damage leading to the long-term inhibition of myofibroblast differentiation and wound healing.

Authors:  James V Jester; Chyong Jy Nien; Vasilis Vasiliou; Donald J Brown
Journal:  Mol Vis       Date:  2012-07-04       Impact factor: 2.367

7.  Outcomes of photorefractive keratectomy with intraoperative mitomycin-C.

Authors:  Mohammad Ghoreishi; Hossein Attarzadeh; Alireza Zandi; Heidar-Ali Moini; Mehdi Tavakoli; Hamid Fesharaki; Kobra Nasrollahi
Journal:  J Ophthalmic Vis Res       Date:  2009-07

8.  Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study.

Authors:  Hassan Hashemi; Seied Mohammad Reza Taheri; Akbar Fotouhi; Azita Kheiltash
Journal:  BMC Ophthalmol       Date:  2004-09-14       Impact factor: 2.209

9.  Topography-guided custom ablation treatment for treatment of keratoconus.

Authors:  Rohit Shetty; Sharon D'Souza; Samaresh Srivastava; R Ashwini
Journal:  Indian J Ophthalmol       Date:  2013-08       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.